Suffolk Capital Management’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-35,377
Closed -$1.17M 154
2015
Q3
$1.17M Sell
35,377
-7,434
-17% -$419K 0.16% 127
2015
Q2
$2.96M Buy
42,811
+5,274
+14% +$364K 0.35% 73
2015
Q1
$2.82M Buy
37,537
+13,113
+54% +$1.03M 0.33% 92
2014
Q4
$2.03M Buy
+24,424
New +$1.98M 0.25% 116

Other funds holding ALIM

Suffolk Capital Management's ALIM Position: Q4 2015 in Review

Suffolk Capital Management sold out of Alimera Sciences (ALIM) in Q4 2015, closing a stake of 35,377 shares — an estimated $1.17M sold.

Suffolk Capital Management first reported a position in ALIM in Q4 2014 and held it in 4 quarters. The position peaked at $2.96M in Q2 2015. 66 funds tracked by Wall St. Rank hold ALIM as of Q4 2015.

  • Suffolk Capital Management reported no remaining Alimera Sciences position as of Q4 2015 after selling out during the quarter.
  • Suffolk Capital Management sold 35,377 Alimera Sciences shares in Q4 2015, an estimated $1.17M.
  • Suffolk Capital Management first reported a position in Alimera Sciences in Q4 2014 and held it in 4 quarters.
  • Suffolk Capital Management's Alimera Sciences position peaked at $2.96M in Q2 2015.
  • 66 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2015.

Based on Suffolk Capital Management's 13F filing for Q4 2015, filed 4 Feb 2016.